Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: The MESA-RV Study

References

• Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, McClure CD, Spinale FG, Zile MR. (2006). Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 113:2089–96.
   PubMed Web of Science ®Google Scholar
• Bahrami H, Bluemke DA, Kronmal R, Bertoni AG, Lloyd-Jones DM, Shahar E, Szklo M, Lima JA. (2008). Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 51:1775–83.
   PubMed Web of Science ®Google Scholar
• Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, Trinh A, Zupan M, Canuet M, Grunebaum L, Brunette A, Desprez D, Chabot F, Weitzenblum E, Freyssinet JM, Chaouat A, Toti F. (2008). Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 177:536–43.
   PubMed Web of Science ®Google Scholar
• Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR, Jr., Kronmal R, Liu K, Nelson JC, O’Leary D, Saad MF, Shea S, Szklo M, Tracy RP. (2002). Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156:871–81.
   PubMed Web of Science ®Google Scholar
• Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, & Folsom AR. (2008). The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 52:2148–55.
   PubMed Web of Science ®Google Scholar
• Cantini-Salignac C, Lartaud I, Schrijen F, Atkinson J, Chabot F. (2006).Metalloproteinase-9 in circulating monocytes in pulmonary hypertension.Fundam Clin Pharmacol 20:405–10.
   Google Scholar
• Chahal H, Johnson W, Tandri H, Jain A, Hundley W, Barr R, Kawut S, Lima JA,Bluemke DA. (2010). Cardiovascular risk factors in relationship to right ventricular structure and function by MRI: the MESA-Right Ventricle study. Am J Cardiol 106:110–16.
   Google Scholar
• Chong AY, Freestone B, Patel J, Lim HS, Hughes E, Blann AD, & Lip GY. (2006). Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. Am J Cardiol 97:671–5.
   PubMed Web of Science ®Google Scholar
• Christ G, Graf S, Huber-Beckmann R, Zorn G, Lang I, Kneussi M, Binder BR, Huber K. (2001). Impairment of the plasmin activation system in primary pulmonary hypertension: evidence for gender differences. Thromb Haemost 86:557–62.
   Google Scholar
• Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP.(1995). Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41:264–70.
   PubMed Web of Science ®Google Scholar
• Declerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I &,Collen D. (1988). Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 71:220–5.
   PubMed Web of Science ®Google Scholar
• Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. (2001). Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103:2055–9.
   Google Scholar
• Diebold I, Djordjevic T, Hess J,Gorlach A. (2008). Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription. Thromb Haemost 100:1021–8.
   PubMed Web of Science ®Google Scholar
• Hankinson J, Kawut S, Shahar E, Smith L, Stukovsky K, Barr R. (2009). Performance of ATS-recommended spirometry reference values in a multiethnic sample of adults: The MESA-Lung Study. Chest 137:138–45.
   Google Scholar
• Heckbert SR, Post W, Pearson GD, Arnett DK, Gomes AS, Jerosch-Herold M, Hundley WG, Lima JA, Bluemke DA. (2006). Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis. J Am Coll Cardiol 48:2285–92.
   PubMed Web of Science ®Google Scholar
• Hoeper MM, Sosada M, Fabel H. (1998). Plasma coagulation profiles in patients with severe primary pulmonary hypertension. Eur Respir J 12:1446–9.
   PubMed Web of Science ®Google Scholar
• Hoffman EA, Jiang R, Baumhauer H, Brooks MA, Carr JJ, Detrano R, Reinhardt J, Rodriguez J, Stukovsky K, Wong ND, Barr RG. (2009). Reproducibility and validity of lung density measures from cardiac CT Scans – The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Acad Radiol 16:689–99.
   PubMed Web of Science ®Google Scholar
• Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. (1995). Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 151:1628–31.
   PubMed Web of Science ®Google Scholar
• Martin I, Humbert M, Marfaing-Koka A, Capron F, Wolf M, Meyer D, Simonneau G, Angles-Cano E. (2002). Plasminogen activation by blood monocytes and alveolar macrophages in primary pulmonary hypertension. Blood Coagul Fibrinolysis 13:417–22.
   Google Scholar
• Natori S, Lai S, Finn JP, Gomes AS, Hundley WG, Jerosch-Herold M, Pearson G, Sinha S, Arai A, Lima JA, Bluemke DA. (2006). Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. AJR Am J Roentgenol 186: S357–65.
   PubMed Web of Science ®Google Scholar
• Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Carmeliet P, Loskutoff DJ, Stern DM. (1998). Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 102:919–28.
   PubMedGoogle Scholar
• Sanchez O, Marcos E, Perros F, Fadel E, Tu L, Humbert M, Dartevelle P, Simonneau G, Adnot S, Eddahibi S. (2007). Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 176:1041–7.
   PubMed Web of Science ®Google Scholar
• Sundstrom J, Evans JC, Benjamin EJ, Levy D, Larson MG, Sawyer DB, Siwik DA, Colucci WS, Sutherland P, Wilson PW, Vasan RS. (2004). Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study. Circulation 109:2850–6.
   PubMed Web of Science ®Google Scholar
• Umar S, Hessel M, Steendijk P, Bax W, Schutte C, Schalij M, van der Wall E, Atsma D, van der Laarse A. (2007). Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension. Pathol Res Pract 203:863–72.
   Google Scholar
• Velagaleti RS, Gona P, Levy D, Aragam J, Larson MG, Tofler GH, Lieb W, Wang TJ, Benjamin EJ, Vasan RS. (2008). Relations of biomarkers representing distinct biological pathways to left ventricular geometry. Circulation 118:2252–8.
   PubMed Web of Science ®Google Scholar
• Vieillard-Baron A, Frisdal E, Eddahibi S, Deprez I, Baker AH, Newby AC, Berger P, Levame M, Raffestin B, Adnot S, d’Ortho MP. (2000). Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats. Circ Res 87:418–25.
   PubMed Web of Science ®Google Scholar
• White RJ, Meoli DF, Swarthout RF, Kallop DY, Galaria, II, Harvey JL, Miller CM, Blaxall BC, Hall CM, Pierce RA, Cool CD,Taubman MB. (2007). Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 293:L583–90.
   Google Scholar